138732-31-7

Basic information

• Product Name: 1-(tert-Butyl)3-methylbicyclo[1.1.1]pentane-1,3-dicarboxylate
• Synonyms: 1-(tert-Butyl)3-methylbicyclo[1.1.1]pentane-1,3-dicarboxylate;Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid, tert-butyl ster methyl ester;(S)-2-(TERT-BUTYLAMINO)-3-((3-(METHOXYCARBONYL)BICYCLO[1.1.1]PENTANE-1-CARBONYL)OXY)PROPANOIC ACID
• CAS NO: 138732-31-7
• Molecular Formula: C₁₂H₁₈O₄
• Molecular Weight: 226.27
• Mol File: 138732-31-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(tert-Butyl)3-methylbicyclo[1.1.1]pentane-1,3-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(tert-Butyl)3-methylbicyclo[1.1.1]pentane-1,3-dicarboxylate(138732-31-7)
• EPA Substance Registry System: 1-(tert-Butyl)3-methylbicyclo[1.1.1]pentane-1,3-dicarboxylate(138732-31-7)

Safety Data

• Hazardous Substances Data: 138732-31-7(Hazardous Substances Data)

Usage

Chemical structure

A bicyclic compound with a tert-butyl and methyl substituent.

Functional groups

Contains two carboxylate functional groups, making it a dicarboxylate ester.

Molecular weight

240.29 g/mol

Applications

Commonly used as a building block in organic synthesis, found in pharmaceutical and industrial applications.

Bicyclic structure

Unique bicyclic structure makes it a valuable precursor for creating complex organic molecules.

Steric hindrance

The tert-butyl and methyl groups provide sterically hindered properties, making it an interesting compound for studying and manipulating in chemical reactions.

Upstream product

• 110371-22-7 methyl 3-(chlorocarbonyl)bicyclo<1.1.1>pentane-1-carboxylate 
• 75-65-0 tert-butyl alcohol 
• 83249-10-9 3‐(methoxycarbonyl)bicyclo[1.1.1]pentane‐1‐carboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 138732-33-9 t-butyl 3-(tosyloxymethyl)bicyclo<1.1.1>pentane-1-carboxylate 
• 138732-34-0 t-butyl 3-(bromomethyl)bicyclo<1.1.1>pentane-1-carboxylate 

Relevant articles and documents

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.

Activation Parameters for Ring Opening of (Bicycloalk-1-yl>methyl Radicals

Ring opening of the (bicyclopent-1-ylmethyl (4), (bicyclohex-1-ylmethyl (5) and (bicyclohept-1-yl)methyl (6) radicals has been investigated by semiempirical molecular orbital theory MINDO/3 and AM1) and by experiment.Our results indic